Impact of antibiotic usage on extended-spectrum β-lactamase producing Escherichia coli prevalence

[1]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[2]  J. Otter,et al.  Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  H. Salimnia,et al.  Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli in children: a case control study , 2019, Infectious diseases.

[4]  E. Larson,et al.  Prior antibiotic use and acquisition of multidrug-resistant organisms in hospitalized children: A systematic review , 2019, Infection Control & Hospital Epidemiology.

[5]  M. Scott,et al.  A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance , 2019, Nature Microbiology.

[6]  Dong Sook Kim,et al.  Analysis of factors affecting antibiotic use at hospitals and clinics based on the defined daily dose , 2018 .

[7]  Bongyoung Kim,et al.  Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital , 2018, Scientific Reports.

[8]  G. Daikos,et al.  Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis. , 2018, International journal of antimicrobial agents.

[9]  R. Humphries,et al.  CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests , 2018, Journal of Clinical Microbiology.

[10]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[11]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[12]  O. Dyar,et al.  What is antimicrobial stewardship? , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  Y. Balykina,et al.  A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption. , 2017, Journal of global antimicrobial resistance.

[14]  M. Oh,et al.  Antibiotic Control Policies in South Korea, 2000-2013 , 2016, Infection & Chemotherapy.

[15]  H. Mikamo,et al.  Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  J. Sohn,et al.  Trends of Antibiotic Consumption in Korea According to National Reimbursement Data (2008–2012) , 2015, Medicine.

[17]  Jun-Ho Koo,et al.  Transfer Function Model Forecasting of Sea Surface Temperature at Yeosu in Korean Coastal Waters , 2014 .

[18]  Diarmaid Hughes,et al.  Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.

[19]  J. Sohn,et al.  Surveillance of Antimicrobial Use and Antimicrobial Resistance , 2008 .

[20]  W. Bilker,et al.  Impact of Different Methods for Describing the Extent of Prior Antibiotic Exposure on the Association Between Antibiotic Use and Antibiotic-Resistant Infection , 2007, Infection Control & Hospital Epidemiology.

[21]  J. Hughes,et al.  Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. , 1997, JAMA.

[22]  J. Schrenzel,et al.  Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  H Mittermayer,et al.  Antimicrobial stewardship. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.